Definitive Contract W81XWH13C0050

<p>The Department of the Army awarded Washburn Therapeutics, Inc. a $241,807.50 firm fixed price, definitive contract for bi-monthly status reports. The contract is set aside as a total small business award and has a completion date of May 1, 2024. Washburn Therapeutics will deliver status reporting services to the Army under the terms of this contract through its completion in 2024 in Pittsburgh, Pennsylvania.</p>

The Department of the Army Medical Command awarded a $148,203.61 Small Business Innovation Research (SBIR) Phase I contract to Haima Therapeutics LLC, a woman-owned small business, for research and development of a nanotechnology-enabled biosynthetic whole-blood surrogate for hemostatic resuscitation. This contract supports the Congressionally Directed Medical Research Programs' Combat Readiness-Medical Research Program under a Rapid Development and Translational Research Award. Additionally,...

The U.S. government agency awarded a Small Business Innovation Research (SBIR) Program Phase I action contract to Aphios Corp, a minority-owned for-profit organization, for the development of anticancer agents. The fixed-price contract, valued at $149,558.00, was awarded on September 30, 2008, with a completion date of May 31, 2009. The contract was a result of a request for proposal (RFP) titled &quot;DEVELOPMENT OF ANTICANCER AGENTS&quot; and was assigned the solicitation number...

This firm-fixed-price SBIR Phase I contract was awarded by the Department of Health and Human Services' National Institute of Allergy and Infectious Diseases to HDT Bio Corp, a for-profit biopharmaceutical company. The $599,629 contract funds the &quot;Rational Development of a Combination Nanoparticle Adjuvant for Influenza&quot;, which involves research and development of novel adjuvants and other medical countermeasures. HDT Bio Corp has previously served as a prime contractor on other HHS...

The Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse awarded a Small Business Innovation Research (SBIR) Program Phase I contract to B &amp; W TEK Inc., a for-profit manufacturing organization, to develop new commercially viable devices, tools, technologies or integrated systems for drug detection and deactivation to deter opioid theft in hospitals. The definitive, firm fixed-price contract has a potential value of $224,656.02 and a...

The U.S. National Cancer Institute awarded a Small Business Innovation Research (SBIR) Phase I contract to Celldex Therapeutics, Inc. in the amount of $199,398.00 on September 20, 2012. The contract is for &quot;OTHER FUNCTIONS - R &amp; D BIOMEDICAL (BASIC RESEARCH)&quot; and has a firm fixed price pricing type. The contract has an ultimate completion date of August 23, 2013. This SBIR Phase I award supports basic research and development activities at Celldex Therapeutics, a for-profit small...

This is a $219,779.00 Small Business Innovation Research (SBIR) Program Phase I contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services (HHS), to Wave 80 Biosciences, Inc., a for-profit small business manufacturer located in San Francisco, California. The contract was awarded on September 3, 2013 and has a completion date of September 29, 2014. The contract is a firm fixed-price definitive contract,...

<p>The U.S. government awarded a $152,363 Small Business Innovation Research (SBIR) Program Phase I contract to LEO Therapeutics, LLC for research on &quot;PYRIDINOPYRIMIDE ANALOGS&quot; under the SBIR 2009 TOPIC 255 solicitation. The definitive, firm-fixed-price contract was awarded by a U.S. government agency and has a period of performance through March 31, 2010. The work will be performed in Palo Alto, California.</p>

The National Heart Lung and Blood Institute awarded a $293,215 Small Business Innovation Research (SBIR) Phase I contract to Technology Holding LLC, a small, minority-owned biotechnology firm based in Salt Lake City, Utah. Under this definitive firm fixed-price contract, the company will conduct research and development on an inhalational apolipoprotein A-I mimetic peptide for the treatment of asthma. The SBIR program, administered across federal agencies, supports small businesses in conducting...

This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Heart Lung and Blood Institute (NHLBI), a civilian agency within the U.S. Department of Health and Human Services (HHS). The contract, valued at $249,723.00, was awarded to Detroit R&amp;D, Inc., a minority-owned, economically disadvantaged, woman-owned small business located in Bloomfield Hills, Michigan. The contract is for research and development of a &quot;Multiplex Label-Free Nanowell Technology...